Thursday, November 8, 2012
Publication and contact
Transgenic rats expressing
as a model for Huntington's disease (HD)
Transgenic rats that
express full-length HTT could help identify new HD therapies. Rats
were generated that expressed a human bacterial artificial chromosome
encoding full-length HTT, including 97 CAG/CAA repeats and all
regulatory elements. The animals developed an early onset, progressive
HD-like phenotype that recapitulated motor and behavioral impairments as well
as brain histopathology. Next steps include a detailed cognitive
characterization of the rat model and additional in vivo imaging
Published online Nov. 8, 2012
Model unpatented; available
Yu-Taeger, L. et al. J.
published online Oct. 31, 2012;
Contact: Huu Phuc Nguyen, University of Tuebingen, Tuebingen,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]